Prosight Management, LP Organogenesis Holdings Inc. Transaction History

Prosight Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $342,760 - $513,000	-38,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$13.71 - $17.18 $176,859 - $221,622	12,900 Added 51.39%	38,000 $541,000
Q2 2021 Aug 13, 2021	BUY	$14.92 - $23.23 $147,230 - $229,233	9,868 Added 64.78%	25,100 $417,000
Q1 2021 May 14, 2021	SELL	$7.33 - $21.06 $14.7 Million - $42.3 Million	-2,008,209 Reduced 99.25%	15,232 $278,000
Q4 2020 Feb 12, 2021	BUY	$3.63 - $7.53 $4.89 Million - $10.1 Million	1,346,888 Added 199.08%	2,023,441 $15.2 Million
Q3 2020 Nov 13, 2020	BUY	$3.29 - $4.58 $463,682 - $645,491	140,937 Added 26.31%	676,553 $2.6 Million
Q2 2020 Aug 14, 2020	SELL	$2.86 - $4.61 $390,844 - $629,997	-136,659 Reduced 20.33%	535,616 $2.06 Million
Q1 2020 May 15, 2020	BUY	$2.92 - $5.31 $158,961 - $289,071	54,439 Added 8.81%	672,275 $2.17 Million
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $2.9 Million - $5.01 Million	617,836 New	617,836 $2.97 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $416M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.